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Leukocyte Esterase Strip Test: Matched for
Musculoskeletal Infection Society Criteria
Eric H. Tischler, BA, Priscilla K. Cavanaugh, MS, and Javad Parvizi, MD, FRCS
Investigation performed at The Rothman Institute at Thomas Jefferson Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania
Background: The presence of leukocyte esterase in the synovial ﬂuid has recently been proposed as a marker for
periprosthetic joint infection. However, the sensitivity and speciﬁcity of leukocyte esterase has not been determined when
matched for the current, most inclusive Musculoskeletal Infection Society (MSIS) criteria for periprosthetic joint infection.
Methods: The presence of leukocyte esterase was prospectively evaluated in synovial joint aspirates from hips and
knees from May 2009 to May 2013. The cohort consisted of 189 hip and knee aspirations (ﬁfty-two positive and 137
negative for infection). If the aspirate was bloody, a centrifuge was used to precipitate red blood cells and obtain clear
synovial ﬂuid. A standard chemical test strip (graded as negative, trace, 1, or 11) was used to detect the presence of
leukocyte esterase. The sensitivity, speciﬁcity, positive predictive value, and negative predictive value of the leukocyte
esterase strip test were calculated using 11 and 11/1 as two positive strip result scenarios.
Results: Synovial ﬂuid was obtained from 221 joints that underwent revision total hip or total knee arthroplasty for either
mechanical failure or periprosthetic infection. Due to the lack of adequate criteria for MSIS criteria classiﬁcation, thirty-two
joints were excluded. The leukocyte esterase test with a threshold of 1/11 had a sensitivity, speciﬁcity, positive
predictive value, and negative predictive value of 79.2% (95% conﬁdence interval [CI], 65.9% to 89.2%), 80.8% (95% CI,
73.3% to 87.1%), 61.8% (95%CI, 49.2% to 73.3%), and 90.1% (95%CI, 84.3% to 95.4%), respectively. Using the11 as a
positive leukocyte esterase result, the sensitivity, speciﬁcity, positive predictive value, and negative predictive value were
66.0% (95% CI, 51.7% to 78.5%), 97.1% (95% CI, 92.6% to 99.2%), 89.7% (95% CI, 75.8% to 97.1%), and 88.0% (95% CI,
81.7% to 92.7%), respectively.
Conclusions: When matched to the current MSIS criteria, the leukocyte esterase strip test yielded a high speciﬁcity,
positive predictive value, negative predictive value, and moderate sensitivity. These results demonstrate that leukocyte
esterase is an accurate, effective marker of periprosthetic joint infection as deﬁned by the MSIS criteria. The leukocyte
esterase strip test is a valuable tool that can be used in conjunction with the current battery of diagnostic tests available.
Level of Evidence: Diagnostic Level II. See Instructions for Authors for a complete description of levels of evidence.
P
eriprosthetic joint infection is one of the most serious
complications after total joint arthroplasty. An esti-
mated 1% to 3% of patients who undergo total joint
arthroplasty subsequently develop a periprosthetic joint in-
fection1-3. Revision arthroplasty is associated with an even
higher prevalence of periprosthetic joint infection for knees
and hips, 5.6% and 3.2%, respectively4. In revision arthro-
plasty, it is vital to preoperatively distinguish between septic
and aseptic failure because the two require different treatment.
The lack of a standard for the diagnosis of periprosthetic
joint infection continues to pose challenges in the orthopaedic
community5. In an effort to provide a universal standard
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deﬁnition of periprosthetic joint infection, the work group of
the Musculoskeletal Infection Society (MSIS) developed diag-
nostic criteria for periprosthetic joint infection6, which were
recently endorsed and updated by an International Consensus
Group on Periprosthetic Joint Infection7. However, the search
for a single diagnostic test that possesses sufﬁcient reliability,
accuracy, sensitivity, and speciﬁcity continues. The need for a
more accurate and efﬁcient test for the diagnosis of peri-
prosthetic joint infection led to the introduction of leukocyte
esterase strip testing of synovial ﬂuid aspirates at our institution8.
Leukocyte esterase is an enzyme secreted by activated
neutrophils that have been recruited to areas of infection8. In
periprosthetic joint infection, neutrophils recruited to the joint
secrete leukocyte esterase that is detectable by colorimetric strip
tests through reactions that result in a color change and that
vary according to the type of strip used8. This simple test re-
quires application of synovial ﬂuid to a urine test strip with
subsequent attention to leukocyte esterase6. Parvizi et al.8
demonstrated that the leukocyte esterase strip test may have a
valuable role in the diagnosis of periprosthetic joint infection,
yielding a sensitivity of 80.6% and a speciﬁcity of 100% for
a11 strip reading. The leukocyte esterase strip test is a quick,
easy-to-perform, cost-effective measure with high sensitivity
and speciﬁcity. Similarly, Wetters et al.9 found the leukocyte
esterase strip test valuable with a sensitivity and speciﬁcity
ranging from 92.9% to 100% and 77.0% to 88.8%, respectively,
for the detection of periprosthestic joint infection. The ranges
were due to the use of different indicators of periprosthetic
joint infection (synovial white blood cell count, positive cul-
tures, and reoperation), which the authors noted as a limitation
since different deﬁnitions of periprosthetic joint infection
could lead to different results9.
This prospective study was designed to test the utility of
the leukocyte esterase strip test for diagnosis of periprosthetic
joint infection when infection was deﬁned using the inclusive
MSIS criteria. Prior literature on the leukocyte esterase test
revealed high sensitivity and speciﬁcity; however, those results
were based on a variety of periprosthetic joint infection deﬁ-
nitions. To our knowledge, this is the ﬁrst study evaluating the
role of the leukocyte esterase strip test for diagnosing peri-
prosthetic joint infection as deﬁned by the current MSIS cri-
teria. Additionally, in the February 2014 Proceedings of the
International Consensus on Periprosthetic Joint Infection, it
was reported that the group voted to include the11 leukocyte
esterase reading as part of the minor MSIS criteria, further
indicating the importance and relevance of this test metric7.
Materials and Methods
On approval of the institutional review board, which allows for surgicalwaste product to be collected without patient consent, we prospectively
performed the leukocyte esterase strip test on 221 consecutive patients who had
revision total knee or hip arthroplasty for either aseptic failure or periprosthetic
infection from March 2009 to May 2013. Of the 221 revision arthroplasties,
thirty-two patients were excluded because of the lack of adequate criteria for
MSIS classiﬁcation.
There were 189 patients in the ﬁnal cohort; ninety-nine (52.4%) of
them were women and ninety (47.6%) were men. Thirty-ﬁve hip and 154
knee arthroplasty revisions were included. The cohort had a mean age and
body mass index (BMI) of sixty-three years (range, twenty-one to ninety
years) and 32.9 kg/m2 (range, 21.1 to 54.2 kg/m2), respectively. Mean serum
erythrocyte sedimentation rate (ESR), serum C-reactive protein (CRP) level,
synovial ﬂuid white blood-cell (WBC) count, and synovial ﬂuid polymor-
phonuclear (PMN) percentage were reported for both the MSIS positive and
negative cohorts (Table I).
We obtained intraoperative synovial ﬂuid from joints undergoing re-
vision total knee and hip arthroplasty. Synovial aspiration was performed just
prior to the arthrotomy, with use of an 18-gauge needle. This was done to
minimize blood contamination of the synovial ﬂuid that interferes with the
leukocyte esterase test. If the synovial ﬂuid had any contaminant, a minimumof
1.5 mL of synovial ﬂuid was transferred to one or more Sarstedt Micro cen-
trifuge tubes (Sarstedt, Nu¨mbrecht, Germany). These tubes were then placed in
a Fisherbrand Mini Centrifuge (dimensions, 16.2 · 15.9 · 10.2 cm; Fisher
Scientiﬁc, Waltham, Massachusetts). The contaminated samples were spun at
maximum speed for 120 to 180 seconds, after which synovial ﬂuid could be
extracted and isolated from nonsynovial ﬂuid, typically, erythrocytes. Aggarwal
et al. previously noted that the use of the centrifuge does not compromise the
accuracy or affect the result of the leukocyte esterase reading
10
. Needle aspi-
ration of this isolated supernatant synovial ﬂuid allows for accurate color-
imetric strip testing using the Chemstrip 7 urine test strip (Roche Diagnostics,
Indianapolis, Indiana).
Immediately following aspiration, one drop of synovial ﬂuid was ap-
plied to the leukocyte test pad of two standard chemical test strips to detect the
presence of leukocyte esterase. Results were recorded after sixty to 120 seconds.
Two leukocyte esterase strips were used per aspiration to ensure the reliability of
the strip result. For each individual synovial ﬂuid sample, the two leukocyte
esterase strips used always had the same reading (negative, trace, 1, or 11).
Leukocyte esterase strip results were analyzed directly in the operating room or
TABLE I Comparison of the Mean Results on Laboratory Tests for the Cohorts with Positive and Negative Findings for Infection According
to MSIS Criteria*
Mean Values
Laboratory Test† MSIS-Negative Cohort (N = 137) MSIS-Positive Cohort (N = 52) P Value
ESR (mm/hr) 24.4 40.40 <0.001
CRP level (mg/dL) 0.96 3.22 0.001
WBC count (cells/mL) 11,511.30 32,795.33 <0.001
PMN percentage 51.51 84.54 <0.001
*MSIS = Musculoskeletal Infection Society. †ESR = erythrocyte sedimentation rate, CRP = C-reactive protein, WBC = white blood cell, and PMN =
polymorphonuclear.
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in the ofﬁce setting. In either circumstance, results were read and interpreted
by trained orthopaedic research fellows. The color of the test strip was read
as negative (white), trace (slightly purple), 1 (light purple), or 11 (dark
purple).
Each joint was then classiﬁed as positive or negative for periprosthetic
joint infection using the MSIS infection criteria
6
:
 There is a sinus tract communicating with the prosthesis; or
 A pathogen is isolated by culture from at least two separate tissue or
ﬂuid samples obtained from the affected prosthetic joint; or
 Three of the following ﬁve criteria exist:
◦ Elevated serum ESR (‡30 mm/hr) and serum CRP concentration
(‡10 mg/L)
◦ Elevated synovial WBC count (‡2000/mL)
◦ Elevated synovial ﬂuid PMN percentage (‡65%)
◦ Presence of purulence in the affected joint
◦ Isolation of microorganism in one culture of periprosthetic tissue
or ﬂuid
Statistical Analysis
We calculated the sensitivity, speciﬁcity, positive predictive value, and negative
predictive value of the leukocyte esterase strip test in diagnosing periprosthetic
joint infection using the MSIS criteria as the standard. The statistical analysis
was conducted in two parts: (1) a 11 reading represented a positive result,
whereas a negative, trace, and 1 reading were all considered negative for in-
fection and (2) a combined 1/11 represented a positive result—i.e., either a
1 result or a 11 result was considered positive for leukocyte esterase, rather
than just a 11 result—while negative and trace were considered negative.
Source of Funding
There was no external funding.
Results
Of the ﬁfty-two patients who were considered to have aninfection according to the MSIS criteria, sixteen had
positive cultures and thirty-six had negative cultures. Table II
provides a distribution of the organisms identiﬁed for patients
with a positive culture. At our institution, all coagulase-negative
Staphylococcus organisms are categorized together.
Of the 221 revision hip and knee joints aspirated, thirty-
two (14.5%) did not have adequate testing to allow evaluation
of the MSIS criteria and were ultimately excluded. Of the
thirty-two patients excluded, 12.5% (four) had incomplete
culture data, 6.3% (two) had incomplete serum data, and
81.3% (twenty-six) had incomplete synovial ﬂuid data, either
as a result of inadequate ﬂuid sample to perform all tests or a
dry tap.
Of the remaining 189 patients, the leukocyte esterase test
was read as negative for eighty-three (44%), trace for thirty-
eight (20%),1 for twenty-nine (15%), and11 for thirty-nine
patients (21%).
When using the MSIS infection criteria as the so-called
gold standard for the diagnosis of periprosthetic joint infection,
the leukocyte esterase test with a threshold of 1/11 had a
sensitivity, speciﬁcity, positive predictive value, and negative
predictive value of 79.2% (95% conﬁdence interval [CI], 65.9%
to 89.2%), 80.8% (95% CI, 73.3% to 87.1%), 61.8% (95% CI,
49.2% to 73.3%), and 90.1% (95% CI, 84.3% to 95.4%), re-
spectively (Table III). Using the 11 as a positive leukocyte
esterase result, the sensitivity, speciﬁcity, positive predictive
value, and negative predictive value were 66.0% (95% CI,
51.7% to 78.5%), 97.1% (95% CI, 92.6% to 99.2%), 89.7%
(95% CI, 75.8% to 97.1%), and 88.0% (95% CI, 81.7% to
92.7%) (Table III).
Discussion
The lack of a universal deﬁnition of periprosthetic jointinfection has made its diagnosis a constant challenge. In an
effort to create a more accurate and universal set of diagnostic
criteria, the MSIS proposed an inclusive deﬁnition of peri-
prosthetic joint infection6 with the intention to eliminate dis-
crepancies between various infection criteria. The adoption of a
common set of diagnostic criteria, although a major step, is
only part of the solution to achieving optimal diagnostic ac-
curacy and efﬁciency. The need for a rapid, accurate, cost-
effective marker for periprosthetic joint infection remains.
The shortcomings of a single diagnostic test for peri-
prosthetic joint infection directed our work toward leukocyte
esterase8. In a prior study, Parvizi et al.8 demonstrated that the
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TABLE III Sensitivity, Speciﬁcity, Positive Predictive Value, and
Negative Predictive Value of Leukocyte Esterase
Matched for MSIS Criteria*
Measurement Outcome Result 95% Conﬁdence Interval
1/11 Threshold
Sensitivity (%) 79.2 65.9-89.2
Speciﬁcity (%) 80.8 73.3-87.1
PPV (%) 61.8 49.2-73.3
NPV (%) 90.1 84.3-95.4
11 Threshold
Sensitivity (%) 66.0 51.7-78.5
Speciﬁcity (%) 97.1 92.6-99.2
PPV (%) 89.7 75.8-97.1
NPV (%) 88.0 81.7-92.7
*MSIS = Musculoskeletal Infection Society, PPV = positive pre-
dictive value, NPV = negative predictive value.
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leukocyte esterase strip had a relatively high sensitivity and
speciﬁcity for detecting periprosthetic joint infection, later
supported by Wetters et al.9. Furthermore, leukocyte esterase
results correlated substantially with four parameters typically
used to screen for periprosthetic joint infection (ESR, CRP,
WBC count, and synovial ﬂuid PMN percentage)8. Together,
these ﬁve parameters could suggest a useful clinical diagnosis of
periprosthetic joint infection.
The purpose of our study was to evaluate the usefulness
of the leukocyte esterase strip test in accurately diagnosing
periprosthetic joint infection as deﬁned by the MSIS criteria.
Our results indicate that the leukocyte esterase strip test re-
mains a valuable diagnostic test for periprosthetic joint infec-
tion when using the MSIS criteria to deﬁne periprosthetic joint
infection. Leukocyte esterase demonstrated a high speciﬁcity,
negative predictive value, and positive predictive value, al-
though the sensitivity was not as high as previously reported
(Table III). Although our data do not support the use of leu-
kocyte esterase as an independent screening method because of
a less than optimal sensitivity, the extremely high speciﬁcity
and negative predictive value in conjunction with other pa-
rameters make it an extremely efﬁcient test to rule out infec-
tion. Additionally, it should be noted that positive predictive
value results are prevalence dependent, meaning that if the
prior probability of infection were very low, then the positive
predictive value would be much lower, even with the same
reported sensitivity and speciﬁcity. Given these ﬁndings, this
would indicate that a trace or negative leukocyte esterase
should allow the surgeon to rule out a periprosthetic infection
with relative certainty. The leukocyte esterase strip test is an
important addition to the group of diagnostic tests available. Its
rapid results (one minute), ease of use, and low cost allow it to
be used both in outpatient and intraoperative settings.
Similar to other current diagnostic methods, the leu-
kocyte esterase strip test has limitations. Any debris or blood
in the synovial aspirate has the potential to skew the results of
the colorimetric test, as exempliﬁed in one-third of the as-
pirates that could not be tested with colorimetric reagents
strips in the study byWetters et al.9. We addressed this concern
by using centrifugation to separate the bloody contaminant
from the synovial ﬂuid in cases of bloody aspirate, a protocol
that preserves the accuracy of the colorimetric test for leu-
kocyte esterase10. Although all individuals were trained to
evaluate the leukocyte esterase strip test results, a possible bias
is introduced because of the subjectivity of leukocyte esterase
strip interpretation.
The future for leukocyte esterase as a marker for peri-
prosthetic joint infection is promising. In revision arthroplasty,
leukocyte esterase may be a more accurate and efﬁcient pre-
dictor of infection at reimplantation than current markers such
as ESR and CRP, which have a low speciﬁcity for periprosthetic
joint infection11,12.
Leukocyte esterase may yield false-positive (11) results
in patients with aseptic loosening of metal-on-metal total hip
replacements because of white blood-cell recruitment to the
joint site of inﬂammation; however, none of the patients with
aseptic loosening of metal-on-metal implants in our cohort
yielded 11 results, suggesting that leukocyte esterase is still
valid in this circumstance. Nevertheless, further research is
required to evaluate the true effects of metal-on-metal total hip
replacement tissue reactions and leukocyte esterase.
In conclusion, detection of leukocyte esterase in synovial
ﬂuid appears to be a highly accurate, simple, rapid, and valu-
able tool for the diagnosis of periprosthetic joint infection,
demonstrating a high speciﬁcity and negative predictive value
for the diagnosis of periprosthetic joint infection when applied
to the MSIS criteria. n
Eric H. Tischler, BA
Priscilla K. Cavanaugh, MS
Javad Parvizi, MD, FRCS
The Rothman Institute at Thomas Jefferson Hospital,
Thomas Jefferson University,
Sheridan Building,
10th Floor, 125 South 9th Street,
Philadelphia, PA 19107.
E-mail address for J. Parvizi: parvj@aol.com
References
1. Phillips JE, Crane TP, Noy M, Elliott TS, Grimer RJ. The incidence of deep pros-
thetic infections in a specialist orthopaedic hospital: a 15-year prospective survey.
J Bone Joint Surg Br. 2006 Jul;88(7):943-8.
2. Kurtz SM, Lau E, Schmier J, Ong KL, Zhao K, Parvizi J. Infection burden for hip and
knee arthroplasty in the United States. J Arthroplasty. 2008 Oct;23(7):984-91. Epub
2008 Apr 10.
3. Ja¨msen E, Varonen M, Huhtala H, Lehto MU, Lumio J, Konttinen YT, Moilanen T.
Incidence of prosthetic joint infections after primary knee arthroplasty. J Arthro-
plasty. 2010 Jan;25(1):87-92. Epub 2008 Dec 04.
4. Hanssen AD, Rand JA. Evaluation and treatment of infection at the site of a total
hip or knee arthroplasty. Instr Course Lect. 1999;48:111-22.
5. Bauer TW, Parvizi J, Kobayashi N, Krebs V. Diagnosis of periprosthetic infection.
J Bone Joint Surg Am. 2006 Apr;88(4):869-82.
6. Parvizi J, Zmistowski B, Berbari EF, Bauer TW, Springer BD, Della Valle CJ, Garvin
KL, Mont MA, Wongworawat MD, Zalavras CG. New deﬁnition for periprosthetic joint
infection: from the Workgroup of the Musculoskeletal Infection Society. Clin Orthop
Relat Res. 2011 Nov;469(11):2992-4.
7. Parvizi J, Gehrke T; International Consensus Group on Periprosthetic Joint In-
fection. Deﬁnition of periprosthetic joint infection. J Arthroplasty. 2014 Jul;29
(7):1331. Epub 2014 Mar 21.
8. Parvizi J, Jacovides C, Antoci V, Ghanem E. Diagnosis of periprosthetic joint
infection: the utility of a simple yet unappreciated enzyme. J Bone Joint Surg Am.
2011 Dec 21;93(24):2242-8.
9. Wetters NG, Berend KR, Lombardi AV, Morris MJ, Tucker TL, Della Valle CJ.
Leukocyte esterase reagent strips for the rapid diagnosis of periprosthetic joint
infection. J Arthroplasty. 2012 Sep;27(8)(Suppl):8-11. Epub 2012 May 17.
10. Aggarwal VK, Tischler E,GhanemE,Parvizi J. Leukocyte esterase fromsynovial ﬂuid
aspirate: a technical note. J Arthroplasty. 2013 Jan;28(1):193-5. Epub 2012 Aug 03.
11. Bedair H, Ting N, Jacovides C, Saxena A, Moric M, Parvizi J, Della Valle CJ. The
Mark Coventry Award: diagnosis of early postoperative TKA infection using synovial
ﬂuid analysis. Clin Ortop Relat Res. 2011 Jan;469(1):34-40.
12. Parvizi J, Ghanem E, Menashe S, Barrack RL, Bauer TW. Periprosthetic
infection: what are the diagnostic challenges? J Bone Joint Surg Am. 2006 Dec;
88(Suppl 4):138-47.
1920
THE JOURNAL OF BONE & JOINT SURGERY d J B J S .ORG
VOLUME 96-A d NUMBER 22 d NOVEMBER 19, 2014
LEUKOCYTE ESTERASE STR IP TEST: MATCHED FOR
MUSCULOSKELETAL INFECT ION SOCIETY CRITER IA
